Fritextsökning
Innehållstyper
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Första priset efter rekorddonationen
I maj 2016 donerade Bengt Sjöberg 2 miljarder kronor - en av de största donationerna i svensk historia. Nu delas det första priset i donationens namn ut. Sjöber...
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Polymer guru new dean at DTU
The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.
-
EMA tillsätter expertgrupp mot Zika
Erbjuder rådgivning kring vetenskapliga och regulatoriska frågor till bolag som utvecklar läkemedel och vaccin mot viruset.
-
Sanionas kokainstudie inledd
Bioteknikföretagets samarbetspartner TRC har påbörjat rekrytering till studien om kokainberoende.
-
Pharma is a safe market
Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Sprint får ny vetenskaplig rådgivare
Cancerforskaren Ravi Amaravadi från USA ska hjälpa bolaget till klinisk fas.
-
535 miljoner till regenerativ medicin
Knut och Alice Wallenbergs Stiftelse finansierar ett nytt forskningscentrum i Lund.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Raysearch igång i Kina
Första patienten ombord i strålstudie.
-
Satsar på tidig forskning
Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Many rotor options for refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Stöd till kvinnliga forskare
17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.